Small-Molecule Strategies against Human Adenoviruses: Progress, Challenges, and Future Perspectives

Keyphrases

• Small Molecules 100%
• Human Adenovirus (HAdV) 100%
• Current Treatment 25%
• Pharmacology 25%
• Medicinal Chemistry 25%
• Drug Development 25%
• FDA-approved Drugs 25%
• Oral Bioavailability 25%
• Antiretroviral Therapy 25%
• Life-limiting Conditions 25%
• Clinical Application 25%
• Virology 25%
• High-throughput 25%
• Drug Discovery 25%
• Health Threat 25%
• Recent Advances 25%
• Screening Method 25%
• Clinical Impact 25%
• Effective Alternative 25%
• Structure-based Design 25%
• Cidofovir 25%
• Nephrotoxicity 25%
• Targeting Strategies 25%
• Molecular Scaffold 25%
• Phenotypic Screening 25%
• Chemical Space 25%
• Drug Repurposing 25%
• Human Adenovirus Infection 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Human Adenovirus C 100%
• Infection 25%
• Drug Development 25%
• Bioavailability 25%
• Pharmaceutical Chemistry 25%
• Drug Discovery 25%
• Antiviral Therapy 25%
• Cidofovir 25%
• Nephrotoxicity 25%
• Molecular Scaffold 25%
• Human Adenovirus Infection 25%
• Diseases 25%

Medicine and Dentistry

• Human Adenovirus C 100%
• Infection 25%
• Bioavailability 25%
• Antiviral Therapy 25%
• Cidofovir 25%
• Nephrotoxicity 25%
• Molecular Scaffold 25%
• Phenotypic Screening 25%
• Human Adenovirus Infection 25%
• Diseases 25%
• Oral 25%